Ultrasound Analysis for Lymphedema
Trial Summary
What is the purpose of this trial?
Researchers are trying to validate the use of ultrasound sub-hertz analysis of viscoelastisty (SAVE) method to monitor tissue-fluid dynamics and stage disease severity in patients diagnosed with lymphedema.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the SAVE Method treatment for lymphedema?
Is ultrasound elastography safe for use in humans?
How does the SAVE Method treatment for lymphedema differ from other treatments?
The SAVE Method is unique because it uses ultrasound to analyze the viscoelastic properties (how tissues stretch and return to shape) of affected tissues, providing a more objective assessment compared to traditional methods that rely on manual examination. This approach can help in better detecting and staging lymphedema by identifying changes in tissue mechanics that are not visible in standard ultrasound images.12678
Research Team
Antonio Forte, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for adults over 18 who have been diagnosed with lymphedema and can give written consent. It's not open to those under 18, anyone unable to consent, or patients who've had certain surgeries like lymphovenous bypass or lymph node transfer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline viscoelasticity parameters are collected using the SAVE method
Follow-up
Participants are monitored for changes in viscoelasticity parameters
Treatment Details
Interventions
- Sub-Hertz Analysis of Viscoelasticity (SAVE) Method
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor